Edward M. Kaye Md.

Companies

• Avidity Biosciences, Inc.Board member Jun 11, 2020 to now¹
• Stoke Therapeutics, Inc.Board member Jun 18, 2019 to now²
• CytokineticsBoard member May 20, 2016 to now³
• Stoke Therapeutics, Inc.Chief executive officer Jun 18, 2019 to Mar 18, 2025²
• Sarepta TherapeuticsBoard member Sep 21, 2016 to Aug 7, 2017⁴
• Sarepta TherapeuticsPresident Sep 21, 2016 to Apr 24, 2017⁴
• Sarepta TherapeuticsChief executive officer Apr 22, 2015 to Apr 24, 2017⁵
• Sarepta TherapeuticsSVP & Chief Medical Officer Jun 20, 2011 to Mar 3, 2015⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• STStoke Therapeutics, Inc. STOK124,557 shares⁷$3.1M at $24.96Aug 18, 2026
• CCytokinetics CYTK10,434 shares⁸$654.8K at $62.76Jul 15, 2026
• ABAvidity Biosciences, Inc.0 shares⁹Feb 27, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 18, 2026Sold 637 shares at $32.47 of Stoke Therapeutics, Inc.⁷
• Aug 18, 2026Sold 11,930 shares at $32.01 of Stoke Therapeutics, Inc.⁷
• Aug 14, 2026Exercised options 26,250 shares of Stoke Therapeutics, Inc.⁷
• Jul 15, 2026Granted 151 shares at $82.62 of Cytokinetics⁸
• Jun 1, 2026Sold 2,933 shares at $76.09 of Cytokinetics¹⁰
• May 27, 2026Granted 2,851 shares of Cytokinetics¹¹
• Apr 15, 2026Granted 191 shares at $65.37 of Cytokinetics¹²
• Mar 15, 2026Exercised options 26,250 shares of Stoke Therapeutics, Inc.¹³
• Mar 15, 2026Exercised options 35,500 shares of Stoke Therapeutics, Inc.¹³
• Feb 27, 2026Returned to company 6,692 shares of Avidity Biosciences, Inc.⁹
• Jan 15, 2026Granted 197 shares at $63.44 of Cytokinetics¹⁴
• Dec 8, 2025Sold 1,331 shares at $33.10 of Stoke Therapeutics, Inc.¹⁵
• Dec 8, 2025Sold 8,274 shares at $32.52 of Stoke Therapeutics, Inc.¹⁵
• Dec 8, 2025Sold 3,825 shares at $31.44 of Stoke Therapeutics, Inc.¹⁵
• Dec 5, 2025Sold 500 shares at $31.85 of Stoke Therapeutics, Inc.¹⁶
• Dec 5, 2025Sold 1,681 shares at $31.15 of Stoke Therapeutics, Inc.¹⁶
• Dec 5, 2025Sold 6,367 shares at $31.33 of Stoke Therapeutics, Inc.¹⁶
• Dec 4, 2025Sold 1,231 shares at $31.32 of Stoke Therapeutics, Inc.¹⁶
• Dec 4, 2025Sold 5,222 shares at $30.76 of Stoke Therapeutics, Inc.¹⁶
• Dec 3, 2025Sold 651 shares at $30.85 of Stoke Therapeutics, Inc.¹⁷
• Dec 3, 2025Sold 419 shares at $30.34 of Stoke Therapeutics, Inc.¹⁷
• Dec 3, 2025Exercised options 26,250 shares of Stoke Therapeutics, Inc.¹⁶
• Dec 2, 2025Sold 405 shares at $30.14 of Stoke Therapeutics, Inc.¹⁷
• Dec 2, 2025Sold 661 shares at $29.56 of Stoke Therapeutics, Inc.¹⁷
• Dec 1, 2025Sold 28,064 shares at $66.72 of Cytokinetics¹⁸